2022 年 8 月，哥伦比亚特区在无特征性皮损或皮疹的 JYNNEOS 疫苗首剂接种者中出现猴痘病毒感染证据。
Evidence of Mpox Virus Infection Among Persons Without Characteristic Lesions or Rash Presenting for First Dose of JYNNEOS Vaccine-District of Columbia, August 2022.
机构信息
Centers for Disease Control and Prevention, Multinational Mpox Response, Atlanta, GA, USA.
Epidemic Intelligence Service, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
出版信息
Clin Infect Dis. 2023 Jul 26;77(2):298-302. doi: 10.1093/cid/ciad145.
PMID:36916132
Abstract
We assessed mpox virus prevalence in blood, pharyngeal, and rectal specimens among persons without characteristic rash presenting for JYNNEOS vaccine. Our data indicate that the utility of risk-based screening for mpox in persons without skin lesions or rash via pharyngeal swabs, rectal swabs, and/or blood is likely limited.
摘要
我们评估了无特征性皮疹但因接种 JYNNEOS 疫苗而就诊者的血液、咽和直肠标本中的猴痘病毒流行率。我们的数据表明，通过咽拭子、直肠拭子和/或血液对无皮肤损伤或皮疹者进行基于风险的猴痘筛查的效用可能有限。
Zotero 插件